This is Friday's PR
https://www.prnewswire.com/news-releases/worl...95841.html
This is from Fridays LA Business Journal
https://labusinessjournal.com/news/2020/dec/1...a-medical/
One difference -
Innova Medical, which is a subsidiary of Pasadena-based private equity firm Pasaca Capital Inc., is a health care and medical device company that during the Covid-19 pandemic has pivoted to making rapid antigen test kits.
The company has shipped up to 4 million test kits from its facilities in Brea, Philadelphia, Hong Kong, Shanghai and Ljubljana, Slovenia.
(Note: worldwide distribution or factories? Asia, Europe, USA)
(I believe that should read 4 million test kits per day...) because the PR says:
With the unprecedented demand for COVID-19 testing, manufacturers need to fortify supply chains to secure the availability of collection devices, assay reagents, and kits. IMG currently ships greater than 4 million rapid antigen test kits per day and expects to double that volume by year-end. Adding a CLIA laboratory to IMG's portfolio streamlines testing workflows with accurate and affordable processing.
https://www.prnewswire.com/news-releases/worl...95841.html
This is from Fridays LA Business Journal
https://labusinessjournal.com/news/2020/dec/1...a-medical/
One difference -
Innova Medical, which is a subsidiary of Pasadena-based private equity firm Pasaca Capital Inc., is a health care and medical device company that during the Covid-19 pandemic has pivoted to making rapid antigen test kits.
The company has shipped up to 4 million test kits from its facilities in Brea, Philadelphia, Hong Kong, Shanghai and Ljubljana, Slovenia.
(Note: worldwide distribution or factories? Asia, Europe, USA)
(I believe that should read 4 million test kits per day...) because the PR says:
With the unprecedented demand for COVID-19 testing, manufacturers need to fortify supply chains to secure the availability of collection devices, assay reagents, and kits. IMG currently ships greater than 4 million rapid antigen test kits per day and expects to double that volume by year-end. Adding a CLIA laboratory to IMG's portfolio streamlines testing workflows with accurate and affordable processing.
1